1)Gleason DF:Classification of prostatic carcinomas. Cancer Chemother Rep 50:125, 1966
2)Epstein JI, Allsbrook WC, Jr, Amin MB, et al:The 2005 International Society of Urological Pathology(ISUP)Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29:1228, 2005
3)日本泌尿器科学会・日本病理学会・日本医学放射線学会:泌尿器科・病理・放射線科 前立腺癌取扱い規約,第4版.金原出版,東京,2010
4)Kato T, Nakano M, Uno H, et al:Discrepancy between Gleason score of needle biopsies and radical prostatectomy specimens:current situation of general pathologists. Hinyokika Kiyo 54:641, 2008
5)Pinthus JH, Witkos M, Fleshner NE, et al:Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy:implication on outcome. J Urol 176:979, 2006
6)Al-Maghrabi JA, Bakshi NA and Farsi HM:Gleason grading of prostate cancer in needle core biopsies:a comparison of general and urologic pathologists. Ann Saudi Med 33:40, 2013
7)Network NCC:Prostate Cancer. NCCN Guidelines, Version 3. 2012:6, 2012
8)D'Amico AV, Whittington R, Malkowicz SB, et al:Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969, 1998
9)Bul M, Zhu X, Valdagni R, et al:Active surveillance for low-risk prostate cancer worldwide:the PRIAS study. Eur Urol 63:597, 2013
10)Kakehi Y, Kamoto T, Shiraishi T, et al:Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer. Jpn J Clin Oncol 38:122, 2008